Gain Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 05/15/2026 | 1.77 M | $3.43 M | 6.47% | 5.37% |
| POTOMAC CAPITAL MANAGEMENT, INC. | 05/14/2026 | 1.01 M | $1.96 M | -0.14% | 3.06% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 631.62 K | $1.16 M | -10.05% | 1.92% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/30/2026 | 568.65 K | $1.10 M | 0.00% | 1.72% |
| DME CAPITAL MANAGEMENT, LP | 05/15/2026 | 566.13 K | $1.10 M | 0.00% | 1.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 447.34 K | $868.53 K | 12.41% | 1.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 431.27 K | $836.66 K | -36.98% | 1.31% |
| 05/15/2026 | 399.89 K | $775.78 K | 100.00% | 1.21% | |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 312.47 K | $606.00 K | 1,426.31% | 0.95% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 229.98 K | $446.16 K | 100.00% | 0.70% |
| BLACKROCK, INC. | 05/13/2026 | 225.05 K | $436.59 K | 7.38% | 0.68% |
| UBS GROUP AG | 05/05/2026 | 220.49 K | $427.75 K | 171.80% | 0.67% |
| JANE STREET GROUP, LLC | 05/12/2026 | 216.88 K | $420.75 K | -10.50% | 0.66% |
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 160.00 K | $310.40 K | 0.00% | 0.49% |
| STATE STREET CORP | 05/15/2026 | 157.54 K | $305.62 K | 0.00% | 0.48% |
| MORGAN STANLEY | 05/15/2026 | 139.65 K | $270.93 K | -5.38% | 0.42% |
| STRATOS WEALTH PARTNERS, LTD. | 04/28/2026 | 131.62 K | $255.35 K | 100.00% | 0.40% |
| NORTHERN TRUST CORP | 05/14/2026 | 114.00 K | $221.15 K | 11.76% | 0.35% |
| LPL FINANCIAL LLC | 05/06/2026 | 104.25 K | $202.25 K | -2.16% | 0.32% |
| JANE STREET GROUP, LLC | 05/12/2026 | 38.60 K | $74.88 K | 100.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 38.30 K | $74.30 K | 25.16% | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 35.82 K | $69.49 K | 0.00% | 0.11% |
| CITADEL ADVISORS LLC | 05/15/2026 | 31.40 K | $60.92 K | 20.31% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 30.00 K | $58.21 K | 0.00% | 0.09% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 29.70 K | $57.62 K | 134.16% | 0.09% |
| APOLLON WEALTH MANAGEMENT, LLC | 04/22/2026 | 26.50 K | $51.41 K | 33.67% | 0.08% |
| CITADEL ADVISORS LLC | 05/15/2026 | 24.90 K | $48.31 K | 100.00% | 0.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 24.50 K | $47.53 K | 100.00% | 0.07% |
| OLIVER LUXXE ASSETS LLC | 04/08/2026 | 20.25 K | $39.29 K | 0.00% | 0.06% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 18.38 K | $35.65 K | 100.00% | 0.06% |
| WEALTHSPIRE ADVISORS, LLC | 05/01/2026 | 16.90 K | $32.79 K | 0.00% | 0.05% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 04/08/2026 | 15.56 K | $28.78 K | 0.00% | 0.05% |
| BENEDICT FINANCIAL ADVISORS INC | 04/20/2026 | 15.50 K | $30.07 K | -59.21% | 0.05% |
| SANDHILL CAPITAL PARTNERS LLC | 05/14/2026 | 15.40 K | $29.88 K | 0.00% | 0.05% |
| MILLINGTON FINANCIAL ADVISORS, LLC | 05/08/2026 | 15.00 K | $29.25 K | 100.00% | 0.05% |
| CITADEL ADVISORS LLC | 05/15/2026 | 14.50 K | $28.13 K | -71.79% | 0.04% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 13.44 K | $26.07 K | -71.97% | 0.04% |
| KESTRA ADVISORY SERVICES, LLC | 04/30/2026 | 12.00 K | $23.28 K | 0.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 11.05 K | $21.44 K | 316.98% | 0.03% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 10.69 K | $21.00 K | 100.00% | 0.03% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 10.60 K | $20.56 K | 0.00% | 0.03% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 6.40 K | $12.42 K | -88.18% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 5.51 K | $10.68 K | -19.73% | 0.02% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.70 K | $3.06 K | 100.00% | 0.01% |
| LARSON FINANCIAL GROUP LLC | 05/15/2026 | 10 | $19 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $2 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Gain Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 60 institutional investors and hedge funds held shares of Gain Therapeutics Inc. The most heavily invested institutionals were:
MARSHALL WACE, LLP: 1.77 M
Potomac Capital Management, Inc.: 1.01 M
JONES FINANCIAL COMPANIES LLLP: 631,615
Cambridge Investment Research Advisors, Inc.: 568,645
DME Capital Management, LP: 566,130
GEODE CAPITAL MANAGEMENT, LLC: 447,342
24.86% of Gain Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 9.16 M shares in the last 24 months. This purchase volume represents approximately $26.84 M in transactions.